Breaking News Instant updates and real-time market news.

ADI

Analog Devices

$72.89

3.07 (4.40%)

, CCL

Carnival

$51.93

0.16 (0.31%)

10:08
11/23/16
11/23
10:08
11/23/16
10:08

On The Fly: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Analog Devices (ADI) upgraded to Buy from Neutral at BofA Merrill Lynch, with analyst Vivek Arya saying Analog's solid fourth quarter alleviates prior concerns regarding sales growth, Apple/consumer exposure, and Linear Technology (LLTC) accretion. 2. Carnival (CCL) upgraded to Outperform from Market Perform at Bernstein, with analyst David Beckel saying the company's results and forward trends have shown "remarkable stability." 3. Autoliv (ALV) upgraded to Neutral from Sell at Goldman with the firm citing valuation. 4. Bank of Montreal (BMO) upgraded to Neutral from Underperform at Credit Suisse with analyst Nick Stogdill citing a moderation in its premium valuation and leverage to rising U.S. interest rates. 5. EdR (EDR) upgraded to Buy from Neutral at BofA Merrill Lynch, with analyst Jeffrey Spector saying EdR has a strong balance sheet and growth, with a low risk development pipeline. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ADI

Analog Devices

$72.89

3.07 (4.40%)

CCL

Carnival

$51.93

0.16 (0.31%)

ALV

Autoliv

$100.99

-0.82 (-0.81%)

BMO

Bank of Montreal

$66.00

0.29 (0.44%)

EDR

EdR

$39.91

-0.15 (-0.37%)

  • 28

    Nov

ADI Analog Devices
$72.89

3.07 (4.40%)

11/23/16
BOFA
11/23/16
UPGRADE
BOFA
Buy
Analog Devices upgraded to Buy from Neutral at BofA/Merrill
11/23/16
11/23/16
UPGRADE
Target $85

Buy
Analog Devices upgraded to Buy on sales growth, accretion at BofA/Merrill
As previously reported, BofA/Merrill upgraded Analog Devices (ADI) to Buy from Neutral and raised its price target to $85 from $70. Analyst Vivek Arya said Analog's solid Q4 alleviates prior concerns regarding sales growth, Apple/consumer exposure, and Linear Technology (LLTC) accretion. Arya believes the Linear acquisition will create a powerful, diversified, and profitable vendor and is forecasting $5+ in FY18 free cash flow.
11/22/16
OPCO
11/22/16
NO CHANGE
Target $85
OPCO
Outperform
Analog Devices price target raised to $85 from $80 at Oppenheimer
Oppenheimer analyst Rick Schafer said Analog Devices' better than expected earnings and guidance show the company is executing at a high level and noted that its Linear Technology acquisition is on track to close in Q2. The analyst raised his price target on the stock to $85 from $80 and keeps an Outperform rating on Analog Devices shares.
11/16/16
MSCO
11/16/16
NO CHANGE
Target $78
MSCO
Overweight
Morgan Stanley positive on Analog Devices ahead of earnings and into 2017
Morgan Stanley analyst Craig Hettenbach said Analog Devices (ADI) is one of his top Overweight picks and sees upside to earnings for the next 2 quarters given strength in broad-based markets and strong opex controls. The analyst expects October quarterly earnings of 90c and $942M, in line with consensus, to prove to be conservative and sees meaningful accretion from the Linear Technology (LLTC) deal adding 84c to 2018 earnings and believes cost savings of $150M will prove to be too low.
CCL Carnival
$51.93

0.16 (0.31%)

11/23/16
BERN
11/23/16
UPGRADE
BERN
Outperform
Carnival upgraded on results, initiatives at Bernstein
As noted earlier, Bernstein upgraded Carnival to Outperform from Market Perform. Analyst David Beckel says that the company's results and forward trends have shown "remarkable stability." He thinks that its initiatives will cause its demand to increase and boost its yields. Target to $68 from $52.
10/27/16
JPMS
10/27/16
DOWNGRADE
Target $73
JPMS
Neutral
Royal Caribbean downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Joseph Greff downgraded Royal Caribbean (RCL) to Neutral saying he does not see a "meaningful fundamental turn" in net yields and pricing for the cruise lines. The analyst lowered his price target for the shares to $73 from $96. Greff this morning also downgraded Norwegian Cruise Line (NCLH) to Neutral and kept a Neutral rating on Carnival (CCL) with a reduced price target of $46.
11/22/16
BERN
11/22/16
UPGRADE
BERN
Outperform
Carnival upgraded to Outperform from Market Perform at Bernstein
11/01/16
11/01/16
NO CHANGE

Royal Caribbean, cruise sector poised to outperform, says Wells Fargo
After Royal Caribbean (RCL) reaffirmed its 2016 guidance and 2017 targets, Wells Fargo thinks that investors are beginning to regain confidence in the cruise sector, The firm expects the sector to outperform through at least early 2017, and it keeps an Outperform rating on Royal Caribbean. Other companies in the sector include Carnival (CCL) and Norwegian Cruise Line (NCLH).
ALV Autoliv
$100.99

-0.82 (-0.81%)

07/25/16
BARD
07/25/16
NO CHANGE
Target $131
BARD
Outperform
Autoliv weakness a buying opportunity, says Baird
Baird said the weakness in Autoliv created an attractive entry point for long-term investors. The firm remains buyers of the shares as they believe the near-term outlook was clouded by its Q2 miss and lower guidance. Baird expects investors to return to the stock given the company's elevated spending levels to support long-term organic growth. Baird reiterated its Outperform rating and lowered its price target to $131 from $137 on Autoliv shares.
11/23/16
GSCO
11/23/16
UPGRADE
Target $95
GSCO
Neutral
Autoliv upgraded to Neutral from Sell at Goldman
Goldman upgraded Autoliv to Neutral citing valuation and lowered its price target to $95 from $101.
10/28/16
BARD
10/28/16
DOWNGRADE
BARD
Neutral
Autoliv downgraded to Neutral from Outperform at Baird
10/28/16
BARD
10/28/16
DOWNGRADE
Target $104
BARD
Neutral
Autoliv downgraded to Neutral at Baird
As reported previously, Baird analyst David Leiker downgraded Autoliv to Neutral from Outperform as organic sales and earnings growth slow on legacy roll-offs in the active safety business. Leiker lowered his price target to $104 from $129 on Autoliv shares.
BMO Bank of Montreal
$66.00

0.29 (0.44%)

11/23/16
FBCO
11/23/16
UPGRADE
FBCO
Neutral
Bank of Montreal upgraded to Neutral from Underperform at Credit Suisse
Credit Suisse analyst Nick Stogdill upgraded Bank of Montreal to Neutral due to a moderation in its premium valuation and leverage to rising U.S. interest rates.
11/01/16
BOFA
11/01/16
INITIATION
Target $66
BOFA
Neutral
Bank of Montreal reinstated with a Neutral at BofA/Merrill
BofA/Merrill analyst Ebrahim Poonawala reinstated Bank of Montreal with a Neutral and a $66 price target.
09/21/16
DUND
09/21/16
INITIATION
DUND
Neutral
Bank of Montreal initiated with a Neutral at Dundee
10/04/16
FBCO
10/04/16
DOWNGRADE
FBCO
Underperform
Bank of Montreal downgraded to Underperform from Neutral at Credit Suisse
EDR EdR
$39.91

-0.15 (-0.37%)

11/17/16
HDLY
11/17/16
UPGRADE
HDLY
Neutral
EdR upgraded to Neutral from Underperform at Hilliard Lyons
11/23/16
BOFA
11/23/16
UPGRADE
BOFA
Buy
EdR upgraded to Buy on growth at BofA/Merrill
As previously reported, BofA/Merrill upgraded EdR from Neutral and maintained its $46 price target. Analyst Jeffrey Spector said EdR has a strong balance sheet and growth, with a low risk development pipeline.
11/23/16
BOFA
11/23/16
UPGRADE
BOFA
Buy
EdR upgraded to Buy from Neutral at BofA/Merrill
10/31/16
10/31/16
NO CHANGE

EdR reports Q3 Core FFO 4c, may not compare to consensus 28c
Reports Q3 revenue $66.23M, consensus $62.09M.

TODAY'S FREE FLY STORIES

AZO

AutoZone

$535.19

-28.21 (-5.01%)

05:26
09/20/17
09/20
05:26
09/20/17
05:26
Recommendations
AutoZone analyst commentary  »

AutoZone results…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 30

    Oct

AGN

Allergan

$215.00

-6.54 (-2.95%)

05:21
09/20/17
09/20
05:21
09/20/17
05:21
Recommendations
Allergan analyst commentary  »

Allergan pipeline largely…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

TRVG

trivago

$10.99

-0.11 (-0.99%)

05:15
09/20/17
09/20
05:15
09/20/17
05:15
Recommendations
trivago analyst commentary  »

trivago price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBBY

Bed Bath & Beyond

$27.03

-0.27 (-0.99%)

05:12
09/20/17
09/20
05:12
09/20/17
05:12
Recommendations
Bed Bath & Beyond analyst commentary  »

Bed Bath & Beyond…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLRN

Acceleron

$38.97

-0.41 (-1.04%)

05:10
09/20/17
09/20
05:10
09/20/17
05:10
Recommendations
Acceleron analyst commentary  »

Acceleron price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

ICPT

Intercept

$96.20

0.45 (0.47%)

05:01
09/20/17
09/20
05:01
09/20/17
05:01
Recommendations
Intercept analyst commentary  »

Intercept recent pullback…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YAHOY

Yahoo Japan

$9.02

-0.03 (-0.33%)

04:57
09/20/17
09/20
04:57
09/20/17
04:57
Downgrade
Yahoo Japan rating change  »

Yahoo Japan downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EPZM

Epizyme

$19.25

1.4 (7.84%)

04:56
09/20/17
09/20
04:56
09/20/17
04:56
Initiation
Epizyme initiated  »

Epizyme initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

CSGP

CoStar Group

$280.60

3.97 (1.44%)

04:55
09/20/17
09/20
04:55
09/20/17
04:55
Conference/Events
CoStar Group management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 21

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

YEXT

Yext

$12.99

-0.27 (-2.04%)

04:55
09/20/17
09/20
04:55
09/20/17
04:55
Conference/Events
Yext management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

FCFS

First Cash Financial

$60.65

0.65 (1.08%)

04:55
09/20/17
09/20
04:55
09/20/17
04:55
Conference/Events
First Cash Financial management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 21

    Sep

  • 22

    Sep

VNRX

VolitionRx

$2.75

0.07 (2.61%)

04:55
09/20/17
09/20
04:55
09/20/17
04:55
Conference/Events
VolitionRx management to meet with Oppenheimer »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 21

    Sep

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 28

    Sep

04:55
09/20/17
09/20
04:55
09/20/17
04:55
Conference/Events
Citigroup to hold a conference »

2017 SMID and Travel…

SRCL

Stericycle

$70.19

-0.81 (-1.14%)

04:55
09/20/17
09/20
04:55
09/20/17
04:55
Conference/Events
Stericycle management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 21

    Sep

  • 27

    Sep

FIVN

Five9

$22.17

0.31 (1.42%)

04:55
09/20/17
09/20
04:55
09/20/17
04:55
Conference/Events
Five9 management to meet with Roth Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 25

    Sep

GMS

GMS Inc.

$33.50

-0.38 (-1.12%)

04:55
09/20/17
09/20
04:55
09/20/17
04:55
Conference/Events
GMS Inc. management to meet with Seaport Global »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

HRTG

Heritage Insurance

$11.83

-0.72 (-5.74%)

04:55
09/20/17
09/20
04:55
09/20/17
04:55
Conference/Events
Heritage Insurance management to meet with Sandler O'Neill »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 21

    Sep

HZNP

Horizon Pharma

$12.10

0.26 (2.20%)

04:55
09/20/17
09/20
04:55
09/20/17
04:55
Conference/Events
Horizon Pharma management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

OHI

Omega Healthcare

$32.53

-0.12 (-0.37%)

04:55
09/20/17
09/20
04:55
09/20/17
04:55
Conference/Events
Omega Healthcare management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

MZDAF

Mazda

04:55
09/20/17
09/20
04:55
09/20/17
04:55
Conference/Events
Mazda management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 21

    Sep

SFS

Smart & Final Stores

04:55
09/20/17
09/20
04:55
09/20/17
04:55
Conference/Events
Smart & Final Stores management to meet with Loop Capital »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

SRCI

SRC Energy

$8.18

0.16 (2.00%)

04:55
09/20/17
09/20
04:55
09/20/17
04:55
Conference/Events
SRC Energy management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 25

    Sep

  • 16

    May

AITB

AIT Therapeutics

04:55
09/20/17
09/20
04:55
09/20/17
04:55
Conference/Events
AIT Therapeutics management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 26

    Sep

ARLP

Alliance Resource Partners

$18.90

-0.05 (-0.26%)

04:55
09/20/17
09/20
04:55
09/20/17
04:55
Conference/Events
Alliance Resource Partners management to meet with MKM Partners »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 21

    Sep

EMR

Emerson

$63.21

0.22 (0.35%)

04:55
09/20/17
09/20
04:55
09/20/17
04:55
Conference/Events
Emerson management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.